A detailed history of Globeflex Capital L P transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 1,044 shares of REGN stock, worth $746,595. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,044
Previous 1,044 -0.0%
Holding current value
$746,595
Previous $1.1 Million -0.0%
% of portfolio
0.11%
Previous 0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $38,932 - $52,457
-71 Reduced 6.37%
1,044 $617,000
Q4 2021

Feb 10, 2022

BUY
$543.48 - $670.97 $438,588 - $541,472
807 Added 262.01%
1,115 $704,000
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $58,551 - $69,457
102 Added 49.51%
308 $186,000
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $28,590 - $35,084
64 Added 45.07%
206 $97,000
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $42,490 - $51,340
78 Added 121.88%
142 $79,000
Q1 2020

May 13, 2020

BUY
$336.18 - $494.43 $21,515 - $31,643
64 New
64 $31,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.